Neurogene
NGNE
60 hedge funds and large institutions have $259M invested in Neurogene in 2020 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 19 increasing their positions, 12 reducing their positions, and 12 closing their positions.
345% more call options, than puts
Call options by funds: $815K | Put options by funds: $183K
58% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 12
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
42% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 12
9% more funds holding
Funds holding: 55 → 60 (+5)
7% more capital invested
Capital invested by funds: $241M → $259M (+$17.5M)
0.95% more ownership
Funds ownership: 2.01% → 2.96% (+0.95%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$21.8M |
| 2 |
Millennium Management
New York
|
+$7.26M |
| 3 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$6.39M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.88M |
| 5 |
Renaissance Technologies
New York
|
+$1.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$4.59M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$2.59M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
-$2.29M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.06M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$874K |
NGNE Hedge Fund Activity: Q1 2020 in Review
60 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q1 2020, worth a combined $259M — up 7.2% from $241M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new NGNE positions and 12 closed out — a net gain of 5 holders — while 19 added to existing stakes and 12 trimmed.
The largest buyer was Redmile Group, adding an estimated $21.8M. The largest seller was Acuta Capital Partners, exiting entirely with an estimated $4.59M sold.
- 60 institutional investors held Neurogene (NGNE) as of Q1 2020, up from 55 in Q4 2019.
- Funds reported $259M of Neurogene stock for Q1 2020, up 7.2% quarter-over-quarter.
- 17 funds opened new Neurogene positions in Q1 2020 and 12 closed out, a net change of +5 holders.
- The largest Neurogene buyer in Q1 2020 was Redmile Group, an estimated $21.8M added.
- The largest Neurogene seller in Q1 2020 was Acuta Capital Partners, an estimated $4.59M sold.
Based on aggregated 13F filings for Q1 2020.